C
2877
vs
JNJ
C
2877
JNJ
Over the past 12 months, China Shineway Pharmaceutical Group Ltd has underperformed JNJ, delivering a return of +38% compared to the JNJ's +46% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
2877
JNJ
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
C
Intrinsic Value
16.3
HKD
Undervaluation 37%
JNJ
Intrinsic Value
172.09
USD
Overvaluation 24%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
10.21
HKD
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
226.16
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
2877, JNJ
2877, JNJ
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
China Shineway Pharmaceutical Group Ltd
Revenue
|
|||||||||||
|
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
2877, JNJ
2877, JNJ
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
|||||||||
|
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
China Shineway Pharmaceutical Group Ltd
72.3%
JNJ
67.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
Operating Margin
China Shineway Pharmaceutical Group Ltd
29.4%
JNJ
27.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
Net Margin
China Shineway Pharmaceutical Group Ltd
30.3%
JNJ
21.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
FCF Margin
China Shineway Pharmaceutical Group Ltd
25.5%
JNJ
20.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
ROE
China Shineway Pharmaceutical Group Ltd
12.2%
JNJ
27.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
ROA
China Shineway Pharmaceutical Group Ltd
9.1%
JNJ
11.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
ROIC
China Shineway Pharmaceutical Group Ltd
22.9%
JNJ
14.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
ROCE
China Shineway Pharmaceutical Group Ltd
11.6%
JNJ
19.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Shineway Pharmaceutical Group Ltd | ||||
|
|
Johnson & Johnson | ||||
Solvency Comparison
C
China Shineway Pharmaceutical Gr...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
2877, JNJ
2877, JNJ
Performance By Year
2877, JNJ
2877, JNJ
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 2877 to other stocks
LLY
Eli Lilly and Co
More expensive
vs China Shineway Pharmaceutical...
ROG
Roche Holding AG
More expensive
vs China Shineway Pharmaceutical...
AZN
AstraZeneca PLC
More expensive
vs China Shineway Pharmaceutical...
NOVN
Novartis AG
More expensive
vs China Shineway Pharmaceutical...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
